Literature DB >> 2661790

Special virulence of the Escherichia coli O1:K1:H7 clone in acute pyelonephritis.

S Mårild1, U Jodal, I Orskov, F Orskov, C Svanborg Edén.   

Abstract

The relationship between acute-phase responses and bacterial properties was studied in a population of 88 children with their first known episode of acute pyelonephritis. One strain from each patient was included in the study. Eighty-four of the patients were infected with Escherichia coli, which was assigned a clonotype according to the O:K:H stereotype; 55 patients carried one of the 12 multiply occurring clones. Globotetraosylceramide-specific (globo+) adhesion was present in 90% of these 12 clones, compared with 62% in the remaining 29 singly occurring clones. The patients infected with globo+ strains had significantly increased inflammatory reactions compared with patients with globo- strains. The O1:K1:H7 strain was the single most frequent clone (n = 14) that always expressed globo+ adhesins. Patients infected with O1:K1:H7 had an inflammatory response similar to that of other globo+ infections, but had a shorter duration of symptoms before diagnosis, higher fever, and higher peripheral leukocyte count. These results demonstrate special virulence of the O1:K1:H7 clone, reflected by the acuteness of onset of infection.

Entities:  

Mesh:

Year:  1989        PMID: 2661790     DOI: 10.1016/s0022-3476(89)80326-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  10 in total

1.  The asymptomatic bacteriuria Escherichia coli strain 83972 outcompetes uropathogenic E. coli strains in human urine.

Authors:  Viktoria Roos; Glen C Ulett; Mark A Schembri; Per Klemm
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

2.  Influence of some bacterial and host factors on colonization and invasiveness of Escherichia coli K1 in neonatal rats.

Authors:  M Wullenweber; L Beutin; S Zimmermann; C Jonas
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

3.  Endotoxin shedding by enterobacteria: free and cell-bound endotoxin differ in Limulus activity.

Authors:  I Mattsby-Baltzer; K Lindgren; B Lindholm; L Edebo
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

4.  Effect of salicylate, bismuth, osmolytes, and tetracycline resistance on expression of fimbriae by Escherichia coli.

Authors:  C M Kunin; T H Hua; R L Guerrant; L O Bakaletz
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

5.  Quantitative differences in adhesiveness of type 1 fimbriated Escherichia coli due to structural differences in fimH genes.

Authors:  E V Sokurenko; H S Courtney; J Maslow; A Siitonen; D L Hasty
Journal:  J Bacteriol       Date:  1995-07       Impact factor: 3.490

6.  Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract.

Authors:  I Connell; W Agace; P Klemm; M Schembri; S Mărild; C Svanborg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

7.  In vivo phase variation of Escherichia coli type 1 fimbrial genes in women with urinary tract infection.

Authors:  J K Lim; N W Gunther; H Zhao; D E Johnson; S K Keay; H L Mobley
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

8.  Endotoxin is angiogenic.

Authors:  I Mattsby-Baltzer; A Jakobsson; J Sörbo; K Norrby
Journal:  Int J Exp Pathol       Date:  1994-06       Impact factor: 1.925

9.  Acute pyelonephritis and renal scarring are caused by dysfunctional innate immunity in mCxcr2 heterozygous mice.

Authors:  Majlis Svensson; Manisha Yadav; Bo Holmqvist; Nataliya Lutay; Catharina Svanborg; Gabriela Godaly
Journal:  Kidney Int       Date:  2011-08-03       Impact factor: 10.612

10.  A broad spectrum anti-bacterial peptide with an adjunct potential for tuberculosis chemotherapy.

Authors:  Komal Umashankar Rao; Domhnall Iain Henderson; Nitya Krishnan; Manoj Puthia; Izabela Glegola-Madejska; Lena Brive; Fanny Bjarnemark; Anna Millqvist Fureby; Karin Hjort; Dan I Andersson; Erik Tenland; Erik Sturegård; Brian D Robertson; Gabriela Godaly
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.